Synovics Pharmaceuticals, Inc.
SYVC
$0.00
$0.000.00%
OTC PK
| 07/31/2009 | 04/30/2009 | 01/31/2009 | 10/31/2008 | 07/31/2008 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1,296.77% | -52.55% | -70.30% | -84.51% | 1,845.66% |
| Total Receivables | -38.98% | -32.80% | -1.49% | 3.13% | 18.14% |
| Inventory | 10.26% | -20.19% | -9.17% | 32.00% | -2.22% |
| Prepaid Expenses | 38.91% | -21.32% | 65.86% | -26.12% | 3.86% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -8.92% | -27.12% | -1.69% | 4.76% | 15.97% |
|
|
|||||
| Total Current Assets | -8.92% | -27.12% | -1.69% | 4.76% | 15.97% |
| Net Property, Plant & Equipment | -5.36% | -3.53% | -2.99% | 1.37% | 16.80% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -12.42% | -11.05% | -6.86% | -9.31% | -58.10% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -25.52% | -67.70% | -43.36% | -66.22% | -28.83% |
| Total Assets | -3.43% | -10.76% | -2.54% | -5.22% | -1.49% |
|
|
|||||
| Total Accounts Payable | 4.96% | 3.19% | 16.51% | 2.00% | 1.58% |
| Total Accrued Expenses | 18.90% | 0.67% | -9.28% | 6.58% | -54.52% |
| Short-term Debt | 296.70% | -15.31% | -9.26% | -77.22% | -80.40% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -16.58% | 30.53% | 6.05% | 24.02% | -10.26% |
| Total Finance Division Other Current Liabilities | 27.09% | 33.32% | 60.64% | -- | -- |
| Total Other Current Liabilities | 27.09% | 33.32% | 60.64% | -- | -- |
| Total Current Liabilities | 13.42% | 7.52% | 6.59% | -4.50% | -51.16% |
|
|
|||||
| Total Current Liabilities | 13.42% | 7.52% | 6.59% | -4.50% | -51.16% |
| Long-Term Debt | -26.09% | -23.33% | -15.49% | -18.39% | -5.43% |
| Short-term Debt | 296.70% | -15.31% | -9.26% | -77.22% | -80.40% |
| Capital Leases | -9.38% | -7.95% | 19.28% | 13.99% | 38.19% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 0.00% |
| Total Liabilities | 7.99% | 1.99% | 2.28% | -11.47% | -43.35% |
|
|
|||||
| Common Stock & APIC | 0.15% | -9.56% | 11.20% | 0.94% | 13.20% |
| Retained Earnings | -2.71% | -3.51% | -1.69% | 0.36% | 0.62% |
| Treasury Stock & Other | 0.00% | 82.21% | -462.15% | -3.47% | 69.35% |
| Total Common Equity | -412.76% | -84.05% | -23.09% | 32.14% | 127.58% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.39% | 3.23% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.39% | 3.23% |
|
|
|||||
| Total Common Equity | -412.76% | -84.05% | -23.09% | 32.14% | 127.58% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.39% | 3.23% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -157.70% | -66.82% | -19.27% | 25.57% | 137.40% |
|
|
|||||